SCHEMBL6946618

SCHEMBL6946618

CCCCCCCCOc1ccc(C#N)cn1

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.63
HPGD P15428 3/20 0.63
KDM4E B2RXH2 3/20 0.63
L3MBTL1 Q9Y468 2/20 0.63
HTT P42858 1/20 0.63
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
GABRA5 P31644 1/20 0.42
NR5A1 Q13285 1/20 0.41
ACACB O00763 3/20 0.40
MGLL Q99685 1/20 0.40
HSD11B1 P28845 3/20 0.39
HSD11B2 P80365 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13347699 0.98 ALDH1A1 (0.61) ALDH1A1HPGDKDM4EL3MBTL1HTT
SCHEMBL27291360 0.93 KDM4E (0.58) ALDH1A1HPGDKDM4EL3MBTL1HTT
SCHEMBL7433167 0.88 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EL3MBTL1HTT
SCHEMBL22120122 0.85 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EL3MBTL1HTT
SCHEMBL17233335 0.84 KDM4E (0.46) ALDH1A1HPGDKDM4EL3MBTL1HTT
SCHEMBL11308751 0.84 CYP3A4 (0.48) ALDH1A1HPGDKDM4EL3MBTL1HTT
SCHEMBL9710156 0.84 CYP3A4 (0.48) ALDH1A1HPGDKDM4EL3MBTL1HTT
SCHEMBL17088421 0.84 CYP3A4 (0.48) ALDH1A1HPGDKDM4EL3MBTL1HTT
SCHEMBL11315003 0.84 CYP3A4 (0.48) ALDH1A1HPGDKDM4EL3MBTL1HTT
SCHEMBL24340323 0.83 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0639189-B1 PYRIDYLPYRIMIDINES, A METHOD OF PREPARING THEM, AND THEIR USE IN LIQUID-CRYSTAL MIXTURES AVENTIS RES & TECH GMBH & CO (DE) 2003-02-19 EP disclosed
US-5464865-A Enzyme inhibitors as antiinflammatory agents ORTHO PHARMACEUTICAL CORPORATION (US) 1995-11-07 US disclosed
US-5443754-A Pyridylpyrimidines, a process for their preparation and their use in liquid-crystalline mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1995-08-22 US disclosed
EP-0639189-A1 PYRIDYLPYRIMIDINES, A METHOD OF PREPARING THEM, AND THEIR USE IN LIQUID-CRYSTAL MIXTURES HOECHST AKTIENGESELLSCHAFT (DE) 1995-02-22 EP disclosed
EP-0639189-A4 PYRIDYLPYRIMIDINES, A METHOD OF PREPARING THEM, AND THEIR USE IN LIQUID-CRYSTAL MIXTURES. AVENTIS RES & TECH GMBH & CO (DE) 1993-09-17 EP disclosed
WO-1992012974-A1 PYRIDYLPYRIMIDINES, A METHOD OF PREPARING THEM, AND THEIR USE IN LIQUID-CRYSTAL MIXTURES HOECHST AKTIENGESELLSCHAFT (DE) 1992-08-06 WO disclosed